Status:
UNKNOWN
Clinical and Economic Evaluation of Neurocognitively-Enhanced Online Cognitive Behavioural Therapy
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Irish Research Council
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To evaluate the clinical efficacy of online cognitive behavioural therapy supplemented with online neurocognitive remediation therapy to improve mood and cognition, decrease relapse rates and optimise...
Detailed Description
Depression is the most prevalent mental disorder with high relapse rates. Direct costs to Europe represent 1% of its total economy. Following usual treatment, mood improves or fully recovers but cogni...
Eligibility Criteria
Inclusion
- scoring a minimum of 14 on the BDI-II,
- internet access
- computer access
- English-speaking fluency
Exclusion
- scoring less than 14 on BDI
Key Trial Info
Start Date :
October 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04010643
Start Date
October 24 2018
End Date
January 31 2022
Last Update
December 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern Denmark
Odense, Denmark